Efficacy and safety of 0.05% ingenol mebutate in the treatment of basal cell carcinoma: A prospective study

• Marine Velin,
• Nathalie Cardot‐Leccia,
• Anne‐Claire Cathelineau,
• Luc Duteil,
• Catherine Queille‐Roussel,
• Thierry Passeron,
• Philippe Bahadoran

Affiliations

Marine Velin

Department of Dermatology Université Nice Côte d’Azur CHU Nice Nice France

Nathalie Cardot‐Leccia

Department of Pathology Université Nice Côte d’Azur CHU Nice Nice France

Anne‐Claire Cathelineau

CPCAD (Center of Clinical Pharmacology Applied to Dermatology) Archet 2 Hospital Nice France

Luc Duteil

CPCAD (Center of Clinical Pharmacology Applied to Dermatology) Archet 2 Hospital Nice France

Catherine Queille‐Roussel

CPCAD (Center of Clinical Pharmacology Applied to Dermatology) Archet 2 Hospital Nice France

Thierry Passeron

Department of Dermatology Université Nice Côte d’Azur CHU Nice Nice France

Philippe Bahadoran

Department of Dermatology Université Nice Côte d’Azur CHU Nice Nice France